Athera Biotechnologies AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Athera Biotechnologies AB - overview
Location
-, -, Sweden
Primary Industry
Biotechnology
About
Athera Biotechnologies AB develops products for the risk assessment and treatment of cardiovascular disease related to inflammatory and immunological mechanisms.
Current Investors
Industrifonden, Östersjöstiftelsen
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Epidemiology, Cardiology
Website
www.athera.se
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Athera Biotechnologies AB - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 416,181 | 203,833 | 225,146 | 56,042 | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | (51.0%) | 10.5% | (75.1%) | (100.0%) | - | - | - | - | - |
| EBITDA (USD) | (37,055,749) | (38,816,872) | 2,755,982 | (3,724,825) | (5,767,314) | (15,153,000) | (41,065,000) | - | - | - |
| Operating Income (USD) | (42,509,109) | (41,184,382) | 25,455 | (4,436,321) | (6,405,709) | (16,782,000) | (41,065,000) | - | - | - |
| Operating Margin | (10214.1%) | (20205.0%) | 11.3% | (7916.1%) | - | - | - | - | - | - |
| % EBITDA Margin | (8903.8%) | (19043.5%) | 1224.1% | (6646.5%) | - | - | - | - | - | - |
| NET Income (USD) | (42,161,742) | (40,929,599) | 38,724 | (4,710,912) | (6,640,503) | (16,781,000) | (41,025,000) | - | - | - |
| % Net Margin | (10130.6%) | (20080.0%) | 17.2% | (8406.0%) | - | - | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.